Your browser doesn't support javascript.
loading
Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models.
Jiang, Hongmei; Xu, Mai; Li, Lin; Grierson, Patrick; Dodhiawala, Paarth; Highkin, Maureen; Zhang, Daoxiang; Li, Qiong; Wang-Gillam, Andrea; Lim, Kian-Huat.
Affiliation
  • Jiang H; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Xu M; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Li L; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Grierson P; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Dodhiawala P; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Highkin M; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Zhang D; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Li Q; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri.
  • Wang-Gillam A; Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
  • Lim KH; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, Missouri. kian-huat.lim@wustl.edu awang@dom.wustl.edu.
Mol Cancer Ther ; 17(10): 2144-2155, 2018 10.
Article in En | MEDLINE | ID: mdl-30065098
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Pyrroles / MAP Kinase Signaling System / Protein Kinase Inhibitors / ErbB Receptors / Phosphoinositide-3 Kinase Inhibitors / Aminopyridines Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Pyrroles / MAP Kinase Signaling System / Protein Kinase Inhibitors / ErbB Receptors / Phosphoinositide-3 Kinase Inhibitors / Aminopyridines Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2018 Document type: Article Country of publication: